Niacin in pharmacological doses alters microRNA expression in skeletal muscle of obese Zucker rats by Couturier, Aline et al.
Niacin in Pharmacological Doses Alters MicroRNA
Expression in Skeletal Muscle of Obese Zucker Rats
Aline Couturier*., Janine Keller., Erika Most, Robert Ringseis, Klaus Eder
Institute of Animal Nutrition and Nutrition Physiology, Justus-Liebig-Universita¨t Giessen, Giessen, Germany
Abstract
Administration of pharmacological niacin doses was recently reported to have pronounced effects on skeletal muscle gene
expression and phenotype in obese Zucker rats, with the molecular mechanisms underlying the alteration of gene
expression being completely unknown. Since miRNAs have been shown to play a critical role for gene expression through
inducing miRNA-mRNA interactions which results in the degradation of specific mRNAs or the repression of protein
translation, we herein aimed to investigate the influence of niacin at pharmacological doses on the miRNA expression
profile in skeletal muscle of obese Zucker rats fed either a control diet with 30 mg supplemented niacin/kg diet or a high-
niacin diet with 780 mg supplemented niacin/kg diet for 4 wk. miRNA microarray analysis revealed that 42 out of a total of
259 miRNAs were differentially expressed (adjusted P-value ,0.05), 20 being down-regulated and 22 being up-regulated,
between the niacin group and the control group. Using a biostatistics approach, we could demonstrate that the most
strongly up-regulated (log2 ratio $0.5) and down-regulated (log2 ratio #20.5) miRNAs target approximately 1,800 mRNAs.
Gene-term enrichment analysis showed that many of the predicted target mRNAs from the most strongly regulated miRNAs
were involved in molecular processes dealing with gene transcription such as DNA binding, transcription regulator activity,
transcription factor binding and in important regulatory pathways such as Wnt signaling and MAPK signaling. In conclusion,
the present study shows for the first time that pharmacological niacin doses alter the expression of miRNAs in skeletal
muscle of obese Zucker rats and that the niacin-regulated miRNAs target a large set of genes and pathways which are
involved in gene regulatory activity indicating that at least some of the recently reported effects of niacin on skeletal muscle
gene expression and phenotype in obese Zucker rats are mediated through miRNA-mRNA interactions.
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Introduction
Niacin (nicotinic acid) is a water-soluble vitamin of the B-
complex involved in many different metabolic reactions as a
precursor of the coenzymes nicotinamide adenine dinucleotide
(NAD) and nicotinamide adenine dinucleotide phosphate (NADP)
[1]. At pharmacological doses (2–6 g/d), niacin has long been used
for the clinical therapy of different forms of dyslipidemia,
particularly hypertriglyceridemia, in humans due to the fact that
niacin has potent lipid-modulating activities (lowering of triacyl-
glycerols (TAG), LDL-cholesterol, and lipoprotein (a), increasing
HDL-cholesterol) [1–5]. Apart from these lipid-modulating effects
of niacin, which have been suggested to involve inhibition of
lipolysis in adipose tissue [4], and reduction of gene expression of
APOC3, which is known to inhibit hydrolysis of VLDL-TAG, in
the liver [6], niacin was also recently reported to have pronounced
effects on skeletal muscle gene expression and skeletal muscle
phenotype in obese Zucker rats [7]. Using this genetic model of
obesity, metabolic syndrome and diabetes, we observed that
administration of a pharmacological dose of niacin for 4 wk causes
a muscle fiber shift from type II (glycolytic) to type I (oxidative) in
skeletal muscle [7]. In addition, we observed that the expression of
genes involved in fatty acid transport, mitochondrial fatty acid
import and oxidation, oxidative phosphorylation and angiogenesis
in skeletal muscle is elevated by niacin administration [7],
indicating a change of the muscle metabolic phenotype towards
a more oxidative one. Moreover, we found that genes encoding
molecular regulators of muscle fiber distribution, like peroxisome
proliferator-activated receptor d (PPARd), PPARc coactivator-1a
(PGC-1a) and PGC-1b, are strongly induced by niacin in skeletal
muscle of the obese Zucker rats [7]. Up-regulation of these
transcription factors by niacin administration is likely responsible
for the muscle fiber switch from type II to type I because PPARd
and PGCs are critical regulators of muscle fiber distribution and
muscle metabolic phenotype [8–12]. It is currently unknown,
however, how pharmacological niacin doses regulate gene
expression in skeletal muscle.
MicroRNAs (miRNAs) represent a relatively newly identified
class of regulatory molecules which have important functions for
gene expression. miRNAs are small (,19–24 nucleotides) endog-
enous RNAs, which regulate gene expression mainly at the
posttranscriptional level through binding to complementary
mRNA sequences leading to degradation of the specific mRNAs
or repression of protein translation, and, thus, inhibition of gene
expression. Whether the mRNA is degraded or protein translation
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is repressed depends largely on the degree of miRNA-mRNA
sequence complementarity. Perfect sequence complementarity has
been shown to result in the cleavage of the mRNA strand, whereas
less complementarity leads to the repression of protein translation
[13,14]. Interestingly, a single miRNA can regulate hundreds of
protein encoding target mRNAs indicating the great regulatory
potential of miRNAs [15,16]. The significant role of miRNAs for
regulating gene expression becomes also evident from estimations
that nearly 30% of the human genes represent miRNA targets
[16].
Recent studies have already shown that several dietary factors,
such as vitamin D, biotin, cholesterol, and conjugated linoleic
acids [17–23], influence miRNA expression in tissues which
indicates that nutrient-gene interactions can be mediated at least
partially by miRNA-mRNA interactions. To our knowledge it has
not been studied yet whether administration of niacin at
pharmacological doses influences miRNA expression. The aim
of the present study, therefore, was to investigate the influence of
niacin at pharmacological doses on the miRNA expression profile
in skeletal muscle of obese Zucker rats. Muscle tissue was used for
miRNA profiling in an attempt to explain some of the recently
observed effects of niacin on skeletal muscle gene expression in this
animal model by an altered expression of miRNAs.
Materials and Methods
Animal experiment
The animal experiment was approved by the local Animal Care
and Use Committee (Regierungspra¨sidium Gieben). As animal
model, we used the obese (fa/fa) Zucker rat (Crl:ZUC-Leprfa;
Charles River, France), which is a widely used genetic model of
obesity, metabolic syndrome and diabetes, and, by comparison
with the lean Zucker rat, exhibits hyperphagia, hyperinsulinemia,
and hyperlipidemia. For this study, we used plasma and muscle
samples from obese Zucker rats of a recently performed
experiment of our group [7], in which twelve, 8- to 10-wk old
male obese Zucker rats were randomly divided in two groups
(control group and niacin group, 6 animals/group). The rats were
fed two different semi-purified diets composed according to the
recommendations of the National Research Council for laboratory
rats [24]. The first diet containing 30 mg supplemented niacin per
kg diet, which was sufficient to cover the niacin requirement, was
fed to the ‘‘control’’ group, whereas the second diet containing
780 mg supplemented niacin (Lonza, Basel, Switzerland) per kg
diet was fed to the ‘‘niacin’’ group. Both diets consisted of (g/kg
diet): corn starch, 530; casein, 200; saccharose, 100; soybean oil,
70; cellulose, 50; minerals, 30; and vitamins, 20. Niacin was added
to the ‘‘niacin’’ diet at the expense of corn starch. The dry
components of the diets were mixed and the mixture pressed
under high pressure in a pelletizing machine (Typ 14–175, Kahl,
Reinbek, Germany) to yield cylindrical pellets. The diets were fed
ad libitum and water was available ad libitum for a period of 28 days.
At the end of the experiment the rats were decapitated under CO2
anesthesia. Blood was collected and plasma obtained by centrifu-
gation, and skeletal muscle (M. rectus femoris) was excised and
immediately stored at 280uC. Further details regarding diet
composition, animal keeping and sample collection are shown in
our previous publication [7]. In Accordance with Article 4 par. 3
of the German Animal Welfare Law all animals were humanely
killed for scientific purpose approved by the Animal Welfare
Officer of the Justus-Liebig-University, JLU No. 450_AZ.
Determination of plasma concentrations of nicotinic acid,
nicotinamide (NAM), and nicotinuric acid (NUA)
The concentrations of nicotinic acid, NAM and NUA in plasma
were determined by LC-MS/MS according to the method from
Liu et al. [25] with slight modifications. Frozen samples were
thawed at RT, centrifuged at 6006g for 2 min, and a 200 ml
aliquot was transferred into a 1.5 ml tube. Then, 10 ml each of
internal standard solution (Oxiracetam) (in methanol) and
methanol/water (5:95, v/v) was added, the tube gently mixed
and after adding 500 ml acetonitrile the mixture was vortexed for
1 min. The mixture was centrifuged at 13,0006g for 10 min at
10uC, and 400 ml of the supernatant was transferred to another
1.5 ml tube. Subsequently, the mixture was evaporated to dryness
at 40uC under a stream of nitrogen. The residue was reconstituted
in 200 ml of methanol/water (10:90, v/v) acidified with 0.1%
formic acid. Finally, the reconstituted solution was centrifugated at
13,0006g for 5 min at RT, and an aliquot of the solution was
injected into the LC-MS/MS system for the analysis. The HPLC
system was a Hitachi LaChromUltra system (Darmstadt, Ger-
many) consisting of the L-2160U solvent delivery modules, an L-
2200U autosampler, an L-2300 column oven, and a system
controller. Chromatography was performed on a Nucleodur
Polartec analytical column (particle size 3 mm, length 150 mm,
internal diameter 3 mm; Macherey-Nagel, Du¨ren, Germany)
fitted with a Nucelodur Polartec EC gurad column (particle size
3 mm, 463 mm; Macherey-Nagel). The mobile phase consisted of
methanol/H2O (10:90, v/v) acidified with 0.1% formic acid. The
flow rate was 0.35 ml/min with column temperature maintained
at 35uC. For mass analysis and detection an API 3200 triple-
quadrupole mass spectrometer (Applied Biosystems/MDS
SCIEX, Darmstadt, Germany) equipped with an electrospray
ionization (ESI) source. Analyst software (Applied Biosystems/
MDS SCIEX, Darmstadt, Germany) was used for data acquisition
and processing. The standard curves were found to be linear in the
range of 0.08–16.4 mmol/l for nicotinic acid, 2.05–40.9 mmol/l for
NAM, and 0.08–16.4 mmol/l for NUA. The mean correlation
coefficient for each analyte was 0.999 and the detection limit was
0.08 mmol/l. The precision estimated by analyzing 3 replicates of
rat plasma was 3.5% for NAM, whereas no signal could be
detected for nicotinic acid and NUA.
RNA isolation
Total RNA, including small RNAs, was isolated from M. rectus
femoris using the Qiagen miRNeasy Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s protocol. The isolated
RNA was used for miRNA microarray analysis and subsequent
qRT-PCR analysis. Concentration of total RNA was determined
using an Infinite 200 M microplate reader and a nanoQuant Plate
(both from Tecan, Ma¨nnedorf, Switzerland) and its integrity was
confirmed by 1% agarose gel electrophoresis. Isolated RNA was
immediately frozen and stored at 280uC.
miRNA microarray analysis
The miRNA microarray analysis was performed by Exiqon
Services (Denmark). Sample total RNA quality was verified using
an Agilent BioAnalyzer 2100 System. MiRCURY LNA micro-
RNA Arrays (7th Gen) following the miRBASE release 18 (http://
www.mirbase.org/) were used to analyze the expression profile of
each sample (Exiqon, Denmark). 750 ng total RNA from sample
and reference was labeled using the mercury LNA microRNA Hi-
Power Labeling Kit, Hy3/Hy5 (Exiqon, Denmark) and were
mixed pair-wise and hybridized according to the instruction
manual using a Tecan HS4800 hybridization station (Tecan,
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Austria). Afterwards, slides were scanned using the Agilent
G2565BA Microarray scanner System (Agilent Technologies,
Inc., USA) and image analysis was carried out the ImaGene 9
(mercury LNA microRNA Array Analysis Software, Exiqon,
Denmark). The quantified signals were background corrected
(Normexp with offset value 10, [27]) and normalized using the
global Lowess (LOcally WEighted Scatterplot Smoothing) regres-
sion algorithm. The signal values were filtered based on absent/
present calls. miRNAs with present calls ,20% were removed
from the final dataset used for the expression analysis. The
microarray data related to all samples have been deposited in
NCBI’s Gene expression Omnibus public repository [28].
qRT-PCR validation of differentially expressed miRNAs
For validation of results from microarray analysis, eight of the
differentially expressed miRNAs identified by microarray analysis
were analyzed by qRT-PCR using a Rotor-Gene 2000 system
(Corbett Research, Mortlake, Australia). For this, cDNA was
synthesized from 0.5 mg of total RNA using the miScript II RT Kit
(Qiagen, Hilden, Germany) according the manufacturer’s protocol
and stored at 220uC in 1:10-diluted aliquots. 2 ml cDNA, 2 ml
miScript Universal Primer (106), 2 ml miScript Primer Assay
(106) and 4 ml RNase free and 10 ml QuantiTect SYBR Green
PCR Master Mix (26) (all from Qiagen, Hilden, Germany) were
mixed and qRT-PCR was performed: 15 min incubation at 95uC,
40 cycles of a three-stage temperature profile of 94uC for 15 sec
and 55uC for 30 sec. Relative changes were calculated using 22DCt
equation [29] using expression level of U6 small nuclear RNA (U6
snRNA) as internal control.
qRT-PCR validation of mRNA targets of differentially
expressed miRNAs
For validation of some of the in silico-predicted target genes, we
determined mRNA levels of a selected set of target genes predicted
from down-regulated and up-regulated miRNAs by means of
qRT-PCR. cDNA synthesis and qPCR were performed as
recently described in detail [30]. For normalization, the three
most stable out of six tested potential reference genes were CANX,
RPL13, TOP1. Characteristics of gene-specific primers are shown
in Table S1.
In silico-target prediction of differentially expressed
miRNAs and functional analysis
In silico-prediction of targets of differentially expressed miRNAs
was carried out using three online free available algorithms,
TargetScan release version 6.2 (http://www.targetscan.org/),
miRanda and miRDB (http://mirdb.org/miRDB/). Functional
analysis of the predicted targets of the most strongly regulated
miRNAs was performed by enrichment analysis of Gene Ontology
(GO) terms and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways using the Database for Annotation, Visualiza-
tion and Integrated Discovery (DAVID) gene annotation tool
(http://david.abcc.ncifcfr.gov/).
Statistical analysis
Data shown are means 6 SD. Data were analyzed by Student’s
t test using Minitab statistical software (Release 13, Minitab Inc.,
State College, PA, USA). Means were considered significantly
different for P,0.05. P-values of microarray data have been
corrected for multiple testing by the Benjamini and Hochberg
adjustment method. miRNAs with an adjusted P-value ,0.05
were considered to be differentially regulated by niacin supple-
mentation.
Results
Growth performance
Initial and final body weights as well as daily body weight gains
did not differ between the control group (367611 g; 507618 g;
4.9860.56 g; n= 6) and the niacin group (357615 g; 500629 g;
5.0060.69 g; n= 6). In addition, daily feed intake and feed
conversion ratio did not differ between the control group
(25.661.4 g/d; 5.1760.35 g feed/g body weight gain; n= 6)
and the niacin group (26.461.9 g/d; 5.3260.44 g feed/g body
weight gain; n= 6).
Plasma concentrations of nicotinic acid and its
metabolites (NAM and NUA)
Rats of the niacin group had higher plasma NAM levels than
those of the control group (9.8861.72 vs. 4.9661.76 mmol/l;
n = 6; P,0.05). Plasma concentrations of nicotinic acid and NUA
were below the limit of detection (0.08 mmol/l) in both groups.
Identification of differentially regulated miRNAs in
skeletal muscle by miRNA expression profiling
miRNA microarray analysis (miCURY LNA microRNA Array
7th Gen) was performed to identify miRNAs regulated by niacin in
M. rectus femoris of obese Zucker rats. The analysis showed that 42
out of a total of 259 miRNAs were differentially expressed
(adjusted P-value ,0.05) between the niacin group and the control
group. Among the 42 differentially expressed miRNAs, 22
miRNAs were down-regulated and 20 miRNAs were up-regulated
in the niacin group compared to the control group. Figure 1
shows the group-specific signal intensities and the associated log2
ratios and fold changes are given in Table S2. The miRNAs with
a log2 ratio $0.5 and a log2 ratio #20.5 were designated as
significantly up- and down-regulated, respectively, by niacin.
According to this filter, 5 miRNAs were significantly up-regulated
and 12 miRNAs were significantly down-regulated by niacin
(Table 1).
Validation of microarray data by qRT-PCR
Validation of microarray data was carried out by qRT-PCR for
eight of the most strongly regulated miRNAs. Table 2 shows that
numerical data obtained from microarray analysis were in line
with those from qRT-PCR analysis. Statistical analysis revealed
that four miRNAs (miR-29b-3p, miR-145-5p, miR-24-2-5p, miR-
665) were significantly regulated (P,0.05), three miRNAs (miR-
21-3p, miR-466b-2-3p, miR-466d) tended to be significantly
regulated (P,0.15), and one miRNA (miR-34a-5p) was not
confirmed to be significantly regulated by qRT-PCR (Table 2).
In silico-target prediction of differentially expressed
miRNAs and functional analysis
Target prediction was performed for the 17 most strongly
regulated miRNAs by using three online free available algorithms.
As shown in Table S3, a total of 1,642 target genes were
predicted for the 12 most strongly down-regulated miRNAs and
144 target genes were identified for the 5 most strongly up-
regulated miRNAs. In order to validate at least some of the in
silico-predicted target genes, we determined mRNA levels of a
selected set of target genes predicted from down-regulated and up-
regulated miRNAs by means of qRT-PCR. As shown in Table 3,
the mRNA levels of 15 out of 17 target genes from down-regulated
miRNAs in skeletal muscle were significantly greater in the niacin
group than in the control group (P,0.05). The mRNA levels of all
target genes of the up-regulated miRNAs in skeletal muscle were
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slightly lower in the niacin group than in the control group, even
though these effects were not significant.
To explore the biological implication of the predicted targets,
we performed gene-term enrichment analysis using Gene Ontol-
ogy (GO) categories (molecular function, cellular component,
biological process) and Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway analysis by using the DAVID
Functional Annotation Chart tool.
Gene-term enrichment analysis of the target genes predicted
from the 5 up-regulated miRNAs revealed that most genes were
involved in enzyme binding, cytoskeletal protein binding, and
protein N-terminus binding (GO category: molecular function; P,
0.01), plasma membrane, cell fraction, membrane fraction, cell
fraction, and cell projection (GO category: cellular component;
P,0.01), and biological adhesion, cell adhesion, actin filament-
based process, and regulation of MAP kinase activity (GO
category: biological process; P,0.01; Figure 2).
For gene-term enrichment analysis of the targets predicted from
the 12 down-regulated miRNAs the stringency of the filter (EASE
score) was set higher (from P,0.01 to P,0.001) due to the
markedly greater number of predicted targets. According to this,
most target genes predicted from the 12 down-regulated miRNAs
were involved in ion binding, DNA binding, transcription
regulator activity, and transcription factor binding (GO category:
molecular function; P,0.001; Figure 3), membrane-enclosed
lumen, intracellular organelle lumen, organelle lumen, and
nuclear lumen (GO category: cellular component; P,0.001;
Figure 3), and regulation of transcription, transcription, intracel-
lular signaling cascade, protein localization, regulation of tran-
scription from RNA polymerase II, and positive regulation of gene
expression (GO category: biological process; P,0.001; Figure 3).
To identify regulatory pathways influenced by the predicted
targets from the up- and down-regulated miRNAs, gene-term
enrichment analysis was performed using the KEGG pathway
database. Enriched KEGG pathways (EASE score ,0.05)
identified from the 144 putative targets of the up-regulated
miRNAs included the MAPK signaling pathway, and those from
the 1,642 putative targets of the down-regulated miRNAs included
neuroactive ligand-receptor interaction, ubiquitin mediated pro-
teolysis, cell cycle, wnt signaling pathway, RNA degradation and
adipocytokine signaling pathway (Table 4).
A further functional analysis of the predicted targets from the 17
most strongly regulated miRNAs was carried out by identifying
those targets which encode transcription factors. From the
approximately 1,800 predicted targets, we identified 49 mRNA
targets encoding transcription factors. According to the Gene-
Cards Human Gene Database (Weizmann Institute of Science),
five out of these transcription factors, namely AFF4, BTF3L4,
Figure 1. Heat map of the differentially expressed miRNAs in M. rectus femoris of obese Zucker rats fed either a control diet with
30 mg supplemented niacin/kg diet (control group) or a high-niacin diet with 780 mg supplemented niacin/kg diet (niacin group)
for 4 wk. Each row represents an individual microRNA and each column represents a sample. The color scale illustrates the relative expression level
of miRNAs. Red color represents an expression level below the reference channel, and green color represents expression higher than the reference.
The codes on the legend are log2-transformed values. Differentially expressed miRNAs chosen with an adjusted P-value ,0.05.
doi:10.1371/journal.pone.0098313.g001
Table 1. Most strongly up-regulated (log2 ratio $0.5) and down-regulated (log2 ratio #20.5) miRNAs in M. rectus femoris of
obese Zucker rats fed either a control diet with 30 mg supplemented niacin/kg diet (control group) or a high-niacin diet with
780 mg supplemented niacin/kg diet (niacin group) for 4 wk.
Probe ID Annotation Log2 ratio FC Adj. P-value*
Up-regulated miRNAs
168586 rno-miR-34a-5p 0.545 1.459 0.036
11040 rno-miR-29b-3p 0.538 1.452 0.021
42641 rno-miR-145-5p 0.531 1.445 0.021
42950 rno-miR-24-2-5p 0.524 1.438 0.270
13485 rno-miR-10a-5p 0.511 1.425 0.261
Down-regulated miRNAs
11221 rno-miR-300-3p 20.507 21.422 0.312
42694 rno-miR-485-3p 20.525 21.439 0.360
42933 rno-miR-466b-5p 20.533 21.447 0.301
42586 rno-miR-466c-5p 20.640 21.558 0.205
148530 rno-miR-466c-3p 20.658 21.578 0.312
42845 rno-miR-125b-2-3p 20.670 21.591 0.205
29575 rno-miR-32-3p 20.688 21.611 0.205
148594 rno-miR-466d 20.703 21.628 0.261
148280 rno-miR-466b-2-3p 20.710 21.636 0.261
148483 rno-miR-466b-1-3p 20.756 21.689 0.306
42770 rno-miR-665 20.888 21.850 0.354
17896 Rno-miR-21-3p 21.095 22.136 0.260
*P-values have been corrected for multiple testing by the Benjamini and Hochberg adjustment method.
doi:10.1371/journal.pone.0098313.t001
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GTF2B, GTF2H1, GTF2H3, belonged to the class general
transcription factors. The remaining transcription factors belonged
to the class specific transcription factors (syn. upstream transcrip-
tion factors). In Table 5, the main functions of these specific
transcription factors provided from GeneCards are summarized.
Discussion
This is the first study reporting about the influence of
pharmacological niacin doses on the miRNA expression profile
in skeletal muscle of obese Zucker rats. We have recently observed
Table 2. Validation of microarray results using qRT-PCR.
Mean fold changes P-value*
miRNAs microarray qRT-PCR microarray qRT-PCR
rno-miR-34a-5p 1.459 1.362 0.036 0.350
rno-miR-29b-3p 1.452 1.572 0.020 0.015
rno-miR-145-5p 1.445 1.783 0.020 0.011
rno-miR-24-2-5p 1.438 1.518 0.027 0.049
rno-miR-21-3p 22.136 21.828 0.026 0.068
rno-miR-665 21.850 21.607 0.035 0.002
rno-miR-466b-2-3p 21.636 21.905 0.026 0.140
rno-miR-466d 21.628 22.151 0.026 0.082
*P-values of microarray data have been corrected for multiple testing by the Benjamini and Hochberg adjustment method.
doi:10.1371/journal.pone.0098313.t002
Table 3. Validation of predicted target mRNAs using qRT-PCR.
Target mRNA Control Niacin P-value*
Fold of control
Target mRNA of up-regulated miRNAs
BDNF 1.0060.27 0.9060.26 0.53
DUSP6 1.0060.28 0.8360.37 0.43
INSIG1 1.0060.12 0.9860.39 0.93
MRAS 1.0060.16 0.9360.39 0.66
SLC6A1 1.0060.30 0.7360.37 0.25
UBE2A 1.0060.31 0.8560.54 0.64
Target mRNA of down-regulated miRNAs
ACSL3 1.0060.32 2.8162.47 0.07
ACSL4 1.0060.53 3.0362.30 0.04
CAV1 1.0060.22 1.7360.30 0.01
CD36 1.0060.41 1.5460.46 0.06
GHR 1.0060.28 2.4560.54 0.01
GK 1.0060.54 1.6260.37 0.03
GLUT4 1.0060.54 3.2960.61 0.01
GLUT8 1.0061.05 4.2461.43 0.01
IGF1 1.0060.41 3.1861.08 0.01
MAPK10 1.0060.24 2.2060.98 0.01
NFACT3 1.0060.43 4.6863.80 0.04
NFKB1 1.0060.34 1.7960.76 0.02
NPY1R 1.0060.25 1.4560.35 0.02
SDHD 1.0060.47 2.3160.38 0.01
SMURF2 1.0060.22 1.4760.49 0.02
SOD2 1.0060.20 3.0461.12 0.01
STAT3 1.0060.39 2.3360.62 0.01
Data are means 6 SD, n = 6 rats/group.
*P-values according to one-way ANOVA.
doi:10.1371/journal.pone.0098313.t003
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in this animal model that administration of a pharmacological
dose of niacin for 4 wk causes a muscle fiber shift from type II to
type I and increases the percentage of type I fibers in skeletal
muscle [7]. In addition, we found that the expression of genes
involved in fatty acid transport, mitochondrial fatty acid import
and oxidation, oxidative phosphorylation and angiogenesis and of
genes encoding molecular regulators of muscle fiber distribution,
like PPARd, PGC-1a and PGC-1b, in skeletal muscle is elevated
by niacin administration [7]. However, the molecular mechanisms
underlying the alteration of gene expression by pharmacological
niacin doses in skeletal muscle are completely unknown. Because
miRNAs have been shown to play a critical role for gene
expression through inducing miRNA-mRNA interactions which
results in the degradation of specific mRNAs or the repression of
protein translation [13,31], we herein investigated alterations in
the miRNA expression profile of skeletal muscle in response to
niacin administration.
As expected, administration of the pharmacological niacin dose
(0.78 g niacin/kg diet) for 4 wk to the obese Zucker rats resulted in
an about 2-fold elevation of plasma NAM levels compared to the
control rats which received a physiological niacin dose sufficient to
cover their niacin requirement. The elevation of plasma NAM
levels was in the same range as reported in other studies, in which
a similar niacin dose was fed to the rats [26,32]. In contrast,
nicotinic acid and NUA could not be detected in plasma of the
niacin group. This finding is also in line with another study [26],
and is explained by the fact that nicotinic acid from the diet is
rapidly converted to the coenzyme NAD in the intestine and liver
and finally converted into NAM which is released into the blood
stream [33].
The main finding of the present study is that administration of
the pharmacological niacin dose for 4 wk caused a significant
alteration of the miRNA expression profile in skeletal muscle of
obese Zucker rats. This was evidenced by the observation that a
total of 42 miRNAs were found to be differentially regulated by
administration of the pharmacological niacin dose. Using a
biostatistics approach, we could demonstrate that the most
strongly up-regulated (log2 ratio $0.5) and down-regulated (log2
ratio #20.5) miRNAs target 144 and 1,642, respectively, mRNAs
indicating that pharmacological niacin doses can influence a large
set of genes through miRNA-mRNA interactions. In an attempt to
elucidate the biological implications of the niacin-induced changes
in miRNA expression, we performed gene-term enrichment
analysis using GO categories and KEGG pathways for the
mRNAs targeted by the differentially regulated miRNAs. Follow-
ing this approach we observed that many of the predicted target
mRNAs from the most strongly down-regulated miRNAs were
involved in DNA binding, transcription regulator activity,
transcription factor binding, regulation of transcription, intracel-
lular signaling cascade, regulation of transcription from RNA
polymerase II, and positive regulation of gene expression. This
indicates that molecular processes dealing with gene transcription
are activated by niacin treatment because the mRNAs from the
down-regulated miRNAs are less targeted and, thus, less degraded.
In line with the influence of niacin on molecular processes dealing
with gene transcription, we identified amongst the predicted
mRNA targets approximately 50 mRNAs encoding transcription
Figure 2. Gene ontology (GO) analysis of the target genes of the 5 up-regulated miRNAs inM. rectus femoris of obese Zucker rats fed
either a control diet with 30 mg supplemented niacin/kg diet (control group) or a high-niacin diet with 780 mg supplemented
niacin/kg diet (niacin group) for 4 wk. The GO terms were sorted by the number of genes in an ascending order from top to bottom (P-value ,
0.005).
doi:10.1371/journal.pone.0098313.g002
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Figure 3. Gene ontology (GO) analysis of the target genes of the 12 down-regulated miRNAs in M. rectus femoris of obese Zucker
rats fed either a control diet with 30 mg supplemented niacin/kg diet (control group) or a high-niacin diet with 780 mg
supplemented niacin/kg diet (niacin group) for 4 wk. The GO terms were sorted by the number of genes in an ascending order from top to
bottom (P-value ,0.001).
doi:10.1371/journal.pone.0098313.g003
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factors, which were classified according to their function into
general and specific transcription factors. The main part belonged
to the class specific transcription factors, which usually bind
upstream of the initiation site to specific recognition sequences of
the regulated gene to stimulate or repress its transcription. Several
of these specific transcription factors, such as HBP1, KLF11,
AHCTF1, ATF1, E2F6, E2F7, HBP1, IRF1, MEF2A, and MIZF,
are known to be involved in cell cycle regulation, whereas others,
like ATF3, FOXC1, HIVEP3, IRF9 and TWIST2, play a role in
cellular stress response. Although it is difficult to directly relate
these functions and the functions of most other specific transcrip-
tion factors to the recently observed niacin-induced changes of the
skeletal muscle phenotype, one exception regards E2F7, which
could be identified as one of the predicted targets of the down-
regulated miRNAs by niacin. While the best-known function of
E2F7 and other members of the E2F family has long been their
role in cell cycle regulation, a very recent study demonstrated that
E2F7 promotes angiogenesis through transcriptional activation of
the vascular endothelial growth factor A (VEGFA) [34]. This
might provide an explanation for the recent finding that niacin
treatment causes an up-regulation of VEGFA and presumably also
VEGFB in skeletal muscle of rats [7] and sheep [35]. The
observation that the minor part of the transcription factors
targeted by the niacin-regulated miRNAs were general transcrip-
tion factors, like AFF4, BTF3L4, GTF2B, GTF2H1, and
GTF2H3, does not exclude an important role for the niacin-
induced muscle fiber switching in obese Zucker rats [7], because
general transcription factors are essential for gene transcription to
occur, because they are part of the large transcription preinitiation
complex that interacts with RNA polymerase directly. Muscle
fiber switching is known to be initiated by up-regulation of the
abovementioned key regulators of muscle fiber distribution, PGC-
1a, PGC-1b, and PPARd [8,9,11,10], but it is possible that
activation of general transcription factors contributes to the
activation of these key regulators. In particular PGC-1a and
PGC-1b regulate the muscle metabolic phenotype by activating a
great number of nuclear receptors and additional transcription
factors, e.g., PGCs co-activate PPARs, nuclear respiratory factor-1
(NRF-1) and estrogen-related receptor a (ERRa), all of which play
central roles in regulating genes involved in fatty acid oxidation,
thermogenesis, oxidative phosphorylation and mitochondrial
biogenesis [11,36]. In addition, both PGCs co-activate the
myocyte enhancer factor 2 (MEF2) family of transcription factors,
which stimulate specifically the expression of MHC genes from
oxidative fibers [10]. These molecular effects on transcription
factor activity likely explain that pharmacological niacin doses up-
regulate specifically the type I fiber-specific MHCI isoform, and
stimulate transcription of genes involved in mitochondrial fatty
acid catabolism, citrate cycle, oxidative phosphorylation, and
thermogenesis [7]. In agreement with this assumption, we found
that CD36 (fatty acid translocase) and CPT1A (carnitine-
palmitoyltransferase 1A), which encode genes involved in cellular
and mitochondrial fatty acid uptake, respectively, were among the
predicted targets of the most strongly down-regulated miRNAs,
implying that CD36 and CPT1A mRNAs are less targeted by the
miRNAs and less degraded. In addition, these findings could be
further substantiated by qRT-PCR measurements of target
mRNAs, which were performed to reinforce our observations
from in silico-target prediction. For instance, we found that CD36,
SDHD (encoding the citrate cycle enzyme succinate-dehydroge-
nase), but also ACSL3 and ACSL4, both of which encode acyl-
CoA synthetases involved in fatty acid activation, were up-
regulated in skeletal muscle of the niacin group compared to the
control group. Moreover, CAV1 encoding the caveolin 1 protein,
which also has been proposed to play a role in cellular fatty acid
uptake [37,38] and was shown to be coordinately expressed with
CD36 in skeletal muscle [39], was also found to be up-regulated in
the niacin group. Collectively, these findings are in line with our
recent findings in obese Zucker rats that niacin stimulates the
expression of genes involved in fatty acid uptake and utilization
and citrate cycle [7]. Thus, our findings suggest that at least some
of the molecular effects of niacin on skeletal muscle phenotype are
mediated through miRNA-mRNA interactions. Further support
for the assumption that niacin exerts some of its effects via the gene
regulatory potential of miRNAs could be provided from gene-term
enrichment analysis using the KEGG pathway database. Namely,
Table 4. KEGG pathway analyses of the predicted target genes of differentially expressed miRNAs with P,0.05.
Pathway P-value* Genes
Putative targets of the up-regulated miRNAs
MAPK signaling pathway 0.025 BDNF, DUSP2, MAP2K1, MRAS, MAP3K7IP2, MAP3K12, DUSP6
Putative targets of the down-regulated miRNAs
Neuroactive ligand-receptor interaction 0.017 CALCR, GABRB3, GRIK1, TRHR, F2RL1, GLRA2, GNRHR, GABBR2, NR3C1,
LPAR1, HCRTR2, CNR1, P2RY1, ADRA2B, GHR, GRID1, GABRA2, GABRA1,
GRIA3, NPY1R, GRIA4, GRM1, ADRB2, P2RY10, AGTR1B, SSTR1, GRM6,
HTR2C
Ubiquitin mediated proteolysis 0.003 UBE2A, SYVN1, XIAP, UBE3A, UBA6, BIRC6, UBE2I, ANAPC10, HERC3,
UBOX5, UBE3C, UBE2C, UBE2B, RBX1, CUL3, UBE2N, ERCC8, EDD4, SIAH1A,
RHOBTB2, SMURF2, BXW11
Wnt signaling pathway 0.023 FZD8, PPP3R1, SMAD3, CXXC4, MAPK10, DAAM1, TCF7L2, PRKX, RBX1,
PRKCB, SIAH1A, JUN, NFAT5, WIF1, PLCB1, FBXW11, MYC, NFATC3
Cell cycle 0.005 CDC7, YWHAZ, CDC14A, RBL2, SMAD3, ANAPC10, CHEK1, YWHAE, RBX1,
CDKN1C, RAD21, HDAC2, BUB1B, CCNA2, MYC, STAG2, STAG1, SMC1B
RNA degradation 0.007 PATL1, PAPOLA, WDR61, CNOT6L, PNPT1, PAPD7, PAPOLG, XRN1, CNOT4,
DDX6, C1D
Adipocytokine signaling pathway 0.014 CD36, SLC2A4, PRKAG2, NFKBIA, MAPK10, ACSL4, ACSL3, STAT3, CPT1A,
CAMKK2, PCK1
*P-values have been corrected for multiple testing by the Benjamini and Hochberg adjustment method.
doi:10.1371/journal.pone.0098313.t004
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we found that RNA degradation was one of the enriched KEGG
pathways identified from the large set of putative targets from the
down-regulated miRNAs. In addition, Wnt signaling pathway,
which is critical for several features of skeletal muscle physiology
including formation of muscle fibers during pre- and postnatal
myogenesis was identified as an enriched signaling pathway. Wnt
signaling also regulates the formation of neuromuscular synapses,
by modulating the differentiation of pre- and postsynaptic
components, particularly regarding the clustering of acetylcholine
receptors on the muscle [40], a fact that probably explains that
plasma membrane, membrane fraction, and synapse were
identified as significantly enriched gene-terms associated with the
mRNAs targeted by the niacin-regulated miRNAs. Moreover, we
showed that the MAPK signaling pathway, which was previously
Table 5. Specific transcription factors identified as predicted targets of up- and down-regulated miRNAs.
Gene symbol Main function
Predicted targets of up-regulated miRNAs
EGR2 learning; long term potentiation
ELF2 Isoform 1: synergistically with RUNX1; Isoform 2: repression of RUNX1-mediated transactivation
HBP1 cell cycle; Wnt pathway
KLF11 cell growth; induction of apoptosis
NFIA metallothionein IIA
TFED T-cell-dependent antibody responses; autophagy
ZFP367 Isoform 1: transcriptional activation of erythroid genes
Predicted targets of down-regulated miRNAs
AHCTF1 nuclear pore complex (NPC); mitosis
ATF1 cell proliferation and transformation; repression of the expression of FTH1 and other antioxidant detoxification genes
ATF3 cellular stress response
CEBPG binding positive regulatory element-I of the IL-4 gene
CNBP specificity to the sterol regulatory element (SRE); sterol-mediated repression
CREM spermatogenesis; spermatid maturation
E2F6 regulation of E2F-dependent genes whose products are required for entry into the cell cycle but not for normal cell cycle progression
E2F7 angiogenesis, DNA damage response; endocycle; placental development
FOXC1 cell viability; resistance to oxidative stress in the eye
FOXG1 brain and telencephalon development
HBP1 cell cycle; Wnt pathway
HIVEP1 T-cell activation; apoptosis
HIVEP3 immunity; inflammation; adult bone formation
HOXC4; HOXD1 part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis
IHX8 neuron and mesenchymal cell differentiation
IRF1 hematopoiesis; immune responses; cell proliferation and differentiation; tumor suppression
IRF9 interferon stimulated genes
MEF2A growth factor- and stress-induced genes; MAPK signaling
MEF2C cardiac morphogenesis and myogenesis; vascular development
MIZF G1/S phase transition
MTF1 metallothionein I
MTF2 embryonic stem cell self-renewal and differentiation
NKX6-1 islet beta cells; insulin
OTX2 development of brain and sense organs
POU4F1 neuronal lineages
PTF1A formation of pancreatic acinar and ductal cells; cerebellar development
RUNX2 osteoblastic differentiation; skeletal morphogenesis
TCF7L2 Wnt signaling pathway; epithelial stem-cell compartment of the small intestine
TWIST2 proinflammatory cytokines; postnatal glycogen storage and energy metabolism
ZNF367 transcriptional activation of erythroid genes
ZFP423 BMP signaling; olfactory neurogenesis
ZNF521 BMP signaling; hematopoietic system
ZFPM2 heart morphogenesis; development of coronary vessels from epicardium
doi:10.1371/journal.pone.0098313.t005
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reported to be regulated by niacin administration [41], is an
enriched KEGG pathway identified from the putative targets of
the niacin-regulated miRNAs. An influence of niacin on MAPK
signaling was also evident from the observation that several
MAPK isoforms including MAP2K1, MAP3K12, MAP3K7IP,
MAP2K1IP1, MAP3K4, MAP4K3, MAP7D2, MAPK10, MAP-
K1IP1L were identified as targets of the niacin-regulated miRNAs.
Since MAPK is an important kinase regulating the function of
proteins via phosphorylation, it is likely that at least some of the
effects of niacin in skeletal muscle are mediated at the
posttranslational level. This assumption is further strengthened
by the finding that CMPK1, IPMK, SGK1, AAK1, CAMKK2,
DCLK1, ETNK1, GALK2, NEK1, NEK8, PANK3, and many
other kinases were found to be targets of the niacin-regulated
miRNAs. Our finding that MAPK signaling is one pathway
affected by the putative targets of the niacin-regulated miRNAs
agrees also with the view that niacin alters expression of genes
involved in muscle fiber distribution through miRNA-mRNA
interactions because MAPK was shown to regulate PGC-1 [42].
Furthermore, the observation that adipocytokine signaling path-
way is amongst the pathways targeted by the niacin-regulated
miRNAs possibly provides an explanation for recently published
anti-inflammatory effects of niacin in adipocytes and macrophages
[43–45].
It remains to be established how niacin mediates its effects on
gene expression in general and miRNA expression in specific in
skeletal muscle because skeletal muscle does not express the niacin
receptor HCA2 making a direct effect of niacin unlikely.
Alterations in the local microcirculatory haemodynamics caused
by dilatation of skeletal muscle arterioles are known to increase
capillary shear stress and, thereby, activate signaling pathways and
gene expression in skeletal muscle via muscle fiber membrane-
bound mechanoreceptors [46]. Although vasodilatation is also one
frequent unwanted side-effect of niacin treatment [47], this effect is
unlikely to contribute to the niacin-induced changes in miRNA
expression in skeletal muscle, because niacin-induced vasodilata-
tion occurs only in the dermal blood vessels and is responsible for
the characteristic reddening of the skin, also called flushing, due to
HCA2 receptor-mediated secretion of vasodilatatory prostaglan-
dins from Langerhans cells and keratinocytes in the skin. However,
it is well documented that niacin besides altering blood levels of
free fatty acids induces several humoral changes, like increases in
the plasma levels of epinephrine, corticosterone, glucagon, growth
hormone, adiponectin and leptin [48–51]. All of these signals were
shown to influence gene expression and cellular signaling in
different tissues, and some of them were even reported to influence
miRNA expression [51,52]. Thus, future studies have to delineate
which of these signals contribute to the alteration of gene
expression in skeletal muscle.
It is important to note that the pharmacological niacin dose
used in the present study was administered as nicotinic acid and
not as NAM. In the European literature, niacin is a collective term
for nicotinic acid and NAM, whereas in the US American
literature niacin is exclusively used for nicotinic acid. Despite the
fact that nicotinic acid and NAM can be converted into each other
in the body [33], the effect of NAM on the miRNA profile may be
different from that of nicotinic acid because NAM and nicotinic
acid possess different pharmacokinetic properties, which amongst
other are responsible for the less-pronounced adverse effects (no
skin flushing) of NAM. Thus, future studies have to clarify whether
nicotinic acid and NAM differ with regard to the miRNA
expression profile in skeletal muscle.
In conclusion, the present study shows for the first time that
pharmacological niacin doses alter the expression of miRNAs in
skeletal muscle of obese Zucker rats. Results obtained from in
silico-target gene prediction show that approximately 1,800
mRNAs are putative targets of niacin-regulated miRNAs. In
addition, biostatistics analysis revealed that the niacin-regulated
miRNAs target a large set of genes and pathways which are
involved in gene regulatory activity indicating that at least some of
the recently reported effects of niacin on transcriptional regulators
of muscle fiber distribution and muscle phenotype are mediated
through miRNA-mRNA interactions. Future experimental vali-
dations (miRNA knockdown, miRNA overexpression) for at least
some of the predicted miRNA-mRNA interactions are necessary
to confirm the results from biostatistics analysis.
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